Cetera Advisor Networks’s BioLineRX BLRX Stock Holding History

Cetera Advisor Networks’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-250	Closed	-$23K	–	1128
2019 Q4	$23K	Buy	+250	New	+$25.7K	﹤0.01%	1238
2019 Q3	–	Sell	-17	Closed	-$4K	–	1202
2019 Q2	$4K	Hold	17	–	–	﹤0.01%	1195
2019 Q1	$4K	Buy	+17	New	+$4.95K	﹤0.01%	1150

Other funds holding BLRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Cetera Advisor Networks's BLRX Position: Q1 2020 in Review

Cetera Advisor Networks sold out of BioLineRX (BLRX) in Q1 2020, closing a stake of 250 shares — an estimated $23K sold.

Cetera Advisor Networks first reported a position in BLRX in Q1 2019 and held it in 3 quarters. The position peaked at $23K in Q4 2019. 13 funds tracked by Wall St. Rank hold BLRX as of Q1 2020.

Cetera Advisor Networks reported no remaining BioLineRX position as of Q1 2020 after selling out during the quarter.
Cetera Advisor Networks sold 250 BioLineRX shares in Q1 2020, an estimated $23K.
Cetera Advisor Networks first reported a position in BioLineRX in Q1 2019 and held it in 3 quarters.
Cetera Advisor Networks's BioLineRX position peaked at $23K in Q4 2019.
13 funds tracked by Wall St. Rank held BioLineRX as of Q1 2020.

Based on Cetera Advisor Networks's 13F filing for Q1 2020, filed 8 May 2020.